FDA has approved this laser for the treatment of chronic lower back pain. This was accomplished in a clinical experiment that was double-blind and placebo-controlled. (After a follow-up assessment after two months) study participants reported a 58% reduction in pain. In the experiment, it was determined that the FX635 was successful in treating persistent lower back pain, and quick clearance of the FX 635 was achieved. The management of pain and the battle against opioids have both benefited greatly from this development. https://urgentway.com/services/lower-back-pain-treatment/